2010 2009 2008 2007 2006 2005 2004
Elusys Therapeutics and Lonza Extend Manufacturing Agreement For Anthim, a New Anthrax Treatment In Late-Stage Development
Elusys Receives Contract for up to $143 Million from the U.S. Federal Government to Fund Advanced Development of Anthim®, a New Treatment for Anthrax
